[Lys15]-Amyloid β-Protein (15-21)
CAS No. ———
[Lys15]-Amyloid β-Protein (15-21)( ——— )
Catalog No. M40761 CAS No. ———
[Lys15]-Amyloid β-Protein (15-21)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name[Lys15]-Amyloid β-Protein (15-21)
-
NoteResearch use only, not for human use.
-
Brief Description[Lys15]-Amyloid β-Protein (15-21)
-
Description[Lys15]-Amyloid β-Protein (15-21)
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight852.1
-
Molecular FormulaC44H69N9O8
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Ac-[Tyr1,D-Phe2]-GRF...
[Ac-Tyr1,D-Phe2]GRF 1-29, amide (human), a growth hormone releasing factor (GRF) analogue, is a vasoactive intestinal peptide (VIP) antagonist.
-
Diflufenzopyr
Diflufenzopyr (SAN 835H), an auxin transport inhibitor, is semicarbazone-type.
-
Milatuzumab
Milatuzumab (MEDI-115) is a humanized monoclonal antibody against CD74. Milatuzumab promotes the production of free radical oxygen and the loss of mitochondrial membrane potential, reduces CD20/CD74 aggregates and cell adhesion, and induces cell death.
Cart
sales@molnova.com